Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: Mao II who wrote (3661)	2/7/1999 8:11:00 PM
From: James Strauss	Read Replies (3) \| Respond to of 13094

PLC... Chairman: Here's a snipit from their last 10q: ""PLC is the first company to receive a PMA from the FDA to commercialize a product for TMR, which is a new surgical procedure used to treat patients suffering from severe coronary artery disease. The Heart Laser System can now be marketed throughout the U.S. for the treatment of the estimated 80,000 domestic patients each year who suffer from severe coronary artery disease (CAD) but cannot be treated with conventional coronary revascularization techniques such as bypass surgery or angioplasty. 80,000 patients that have no other options plus a portion of the bigger market where they may choose PLC... Jim